181 related articles for article (PubMed ID: 25841679)
1. Emerging therapies for pancreas neuroendocrine cancers.
Mahjoub AR; O'Reilly EM
Chin Clin Oncol; 2013 Sep; 2(3):23. PubMed ID: 25841679
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatment of neuroendocrine tumors with hepatic metastases.
Demirkan BH; Eriksson B
Turk J Gastroenterol; 2012; 23(5):427-37. PubMed ID: 23161287
[TBL] [Abstract][Full Text] [Related]
3. Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.
Capozzi M; Caterina I; De Divitiis C; von Arx C; Maiolino P; Tatangelo F; Cavalcanti E; Di Girolamo E; Iaffaioli RV; Scala S; Tafuto S;
Int J Surg; 2015 Sep; 21 Suppl 1():S89-94. PubMed ID: 26123382
[TBL] [Abstract][Full Text] [Related]
4. Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.
Ito T; Lee L; Jensen RT
Expert Opin Pharmacother; 2016 Nov; 17(16):2191-2205. PubMed ID: 27635672
[TBL] [Abstract][Full Text] [Related]
5. Management of functional neuroendocrine tumors of the pancreas.
Öberg K
Gland Surg; 2018 Feb; 7(1):20-27. PubMed ID: 29629316
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of neuroendocrine tumours.
Cuthbertson DJ; Shankland R; Srirajaskanthan R
Clin Med (Lond); 2023 Mar; 23(2):119-124. PubMed ID: 36958842
[TBL] [Abstract][Full Text] [Related]
7. Recent Updates in the Management of Advanced Pancreatic Neuroendocrine Tumors.
Cho CM
Korean J Gastroenterol; 2019 Mar; 73(3):124-131. PubMed ID: 31013555
[TBL] [Abstract][Full Text] [Related]
8. Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas.
Fazio N; Cinieri S; Lorizzo K; Squadroni M; Orlando L; Spada F; Maiello E; Bodei L; Paganelli G; Delle Fave G; de Braud F
Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S87-94. PubMed ID: 21129617
[TBL] [Abstract][Full Text] [Related]
9. Imaging of neuroendocrine tumors of the pancreas.
Dromain C; Déandréis D; Scoazec JY; Goere D; Ducreux M; Baudin E; Tselikas L
Diagn Interv Imaging; 2016 Dec; 97(12):1241-1257. PubMed ID: 27876341
[TBL] [Abstract][Full Text] [Related]
10. [Current developments in the treatment of neuroendocrine tumors].
Kiesewetter-Wiederkehr B; Melhorn P; Scheuba C; Raderer M
Radiologie (Heidelb); 2024 Jul; 64(7):568-574. PubMed ID: 38649498
[TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine tumors of the gastrointestinal tract].
Arnold C
Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
[TBL] [Abstract][Full Text] [Related]
12. Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies.
Dumlu EG; Karakoç D; Özdemir A
Int Surg; 2015 Jun; 100(6):1089-97. PubMed ID: 25590518
[TBL] [Abstract][Full Text] [Related]
13. Medical Therapy of Gastrointestinal Neuroendocrine Tumors.
Öberg K
Visc Med; 2017 Oct; 33(5):352-356. PubMed ID: 29177164
[TBL] [Abstract][Full Text] [Related]
14. Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids.
Naraev BG; Ramirez RA; Kendi AT; Halfdanarson TR
Clin Lung Cancer; 2019 May; 20(3):e376-e392. PubMed ID: 30910575
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of gastroenteropancreatic neuroendocrine tumors.
Rinke A; Michl P; Gress T
Cancers (Basel); 2012 Feb; 4(1):113-29. PubMed ID: 24213230
[TBL] [Abstract][Full Text] [Related]
17. New treatment options for patients with advanced neuroendocrine tumors.
Chan JA; Kulke MH
Curr Treat Options Oncol; 2011 Jun; 12(2):136-48. PubMed ID: 21437592
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine neoplasms.
Hörsch D; Bert T; Schrader J; Hommann M; Kaemmerer D; Petrovitch A; Zaknun J; Baum RP
Minerva Gastroenterol Dietol; 2012 Dec; 58(4):401-26. PubMed ID: 23207615
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors.
Zandee WT; Brabander T; Blažević A; Kam BLR; Teunissen JJM; Feelders RA; Hofland J; de Herder WW
J Clin Endocrinol Metab; 2019 Apr; 104(4):1336-1344. PubMed ID: 30566620
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacologic therapy for neuroendocrine tumours].
Petrányi A; Bodoky G
Orv Hetil; 2011 Mar; 152(10):379-91. PubMed ID: 21354954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
